Publications by authors named "Genaro H Mendoza-Zavala"

Rationale & Objective: Peritoneal dialysis (PD) solutions provide both clearance of uremic toxins and sodium and water. An intraperitoneal (IP) solution of icodextrin and glucose designed without the requirement for uremic toxin clearance could provide substantially greater sodium and water removal than PD solutions.

Study Design: We examined varying concentrations of icodextrin and dextrose IP solutions in rats.

View Article and Find Full Text PDF

Aims: Incomplete decongestion due to lack of titration of diuretics to effective doses is a common reason for readmission in patients with acute decompensated heart failure (ADHF). The natriuretic response prediction equation (NRPE) is a novel tool that proved to be rapid and accurate to predict natriuretic response and does not need urine collection. However, the NRPE has not been externally validated.

View Article and Find Full Text PDF

Chronic heart failure continues to be one of the main causes of impairment in the functioning and quality of life of people who suffer from it, as well as one of the main causes of mortality in our country and around the world. Mexico has a high prevalence of risk factors for developing heart failure, such as high blood pressure, diabetes, and obesity, which makes it essential to have an evidence-based document that provides recommendations to health professionals involved in the diagnosis and treatment of these patients. This document establishes the clinical practice guide (CPG) prepared at the initiative of the Mexican Society of Cardiology (SMC) in collaboration with the Iberic American Agency for the Development and Evaluation of Health Technologies, with the purpose of establishing recommendations based on the best available evidence and agreed upon by an interdisciplinary group of experts.

View Article and Find Full Text PDF
Article Synopsis
  • * In a randomized trial with 70 stable heart failure patients, those restricted to 2g sodium/day showed no significant changes in N-terminal pro-B-type natriuretic peptide (NT-proBNP) or quality of life compared to a control group consuming 3g sodium/day.
  • * Only patients who reduced their sodium intake to below 2500mg/day experienced notable improvements in NT-proBNP levels and quality of life, suggesting that stricter adherence to sodium limitations may be beneficial without additional safety risks.
View Article and Find Full Text PDF